US Stock MarketDetailed Quotes

Lexicon Pharmaceuticals (LXRX)

Watchlist
  • 1.680
  • 0.0000.00%
Close Apr 24 16:00 ET
  • 1.690
  • +0.010+0.60%
Post 20:01 ET
711.78MMarket Cap-12.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lexicon Pharmaceuticals (LXRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
60.24%49.8M
-79.31%5.49M
710.40%14.18M
1,652.64%28.87M
11.68%1.26M
2,481.48%31.08M
3,682.62%26.55M
980.25%1.75M
419.56%1.65M
4,608.33%1.13M
Operating revenue
60.24%49.8M
-79.31%5.49M
710.40%14.18M
1,652.64%28.87M
11.68%1.26M
2,481.48%31.08M
3,682.62%26.55M
980.25%1.75M
419.56%1.65M
4,608.33%1.13M
Cost of revenue
-55.52%274K
-42.24%201K
-85.92%10K
-80.12%33K
-3.23%30K
624.71%616K
397.14%348K
914.29%71K
1,975.00%166K
31K
Gross profit
62.58%49.53M
-79.81%5.29M
744.07%14.17M
1,846.86%28.83M
12.10%1.23M
2,622.52%30.47M
4,046.52%26.21M
983.23%1.68M
379.29%1.48M
4,479.17%1.1M
Operating expense
-56.75%98.44M
-65.95%20.07M
-59.68%26.36M
-55.84%25.1M
-42.04%26.91M
31.65%227.58M
24.43%58.94M
31.31%65.37M
27.58%56.84M
48.98%46.43M
Selling and administrative expenses
-73.92%37.32M
-72.85%8.76M
-80.80%7.6M
-76.14%9.35M
-63.79%11.61M
25.55%143.1M
-1.07%32.26M
22.85%39.59M
30.61%39.19M
67.50%32.06M
-General and administrative expense
----
----
----
----
----
----
----
----
----
67.50%32.06M
Research and development costs
-27.65%61.12M
-57.60%11.32M
-27.24%18.76M
-10.75%15.75M
6.48%15.3M
43.46%84.48M
80.77%26.69M
46.83%25.78M
21.33%17.64M
19.51%14.37M
Operating profit
75.19%-48.91M
54.85%-14.78M
80.87%-12.19M
106.75%3.74M
43.35%-25.68M
-14.77%-197.12M
29.95%-32.74M
-28.33%-63.69M
-25.12%-55.35M
-45.57%-45.33M
Net non-operating interest income expense
56.48%-1.43M
27.11%-750K
47.94%-582K
-125.14%-484K
112.53%384K
38.80%-3.29M
65.92%-1.03M
-25.06%-1.12M
389.91%1.93M
-286.87%-3.06M
Non-operating interest income
-43.80%6.91M
-54.72%1.28M
-54.33%1.57M
-55.66%1.83M
17.78%2.22M
58.99%12.29M
17.78%2.83M
14.61%3.44M
219.14%4.14M
83.09%1.88M
Non-operating interest expense
-46.47%8.34M
-47.36%2.03M
-52.76%2.16M
4.84%2.32M
-62.91%1.84M
18.91%15.58M
-28.83%3.86M
17.00%4.56M
12.81%2.21M
171.72%4.95M
Other net income (expense)
Income before tax
74.88%-50.34M
54.01%-15.53M
80.30%-12.77M
106.09%3.25M
47.73%-25.3M
-13.15%-200.4M
32.14%-33.77M
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.4M
Income tax
Net income
74.88%-50.34M
54.01%-15.53M
80.30%-12.77M
106.09%3.25M
47.73%-25.3M
-13.15%-200.4M
32.14%-33.77M
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.4M
Net income continuous Operations
74.88%-50.34M
54.01%-15.53M
80.30%-12.77M
106.09%3.25M
47.73%-25.3M
-13.15%-200.4M
32.14%-33.77M
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.4M
Minority interest income
Net income attributable to the parent company
74.88%-50.34M
54.01%-15.53M
80.30%-12.77M
106.09%3.25M
47.73%-25.3M
-13.15%-200.4M
32.14%-33.77M
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
74.88%-50.34M
54.01%-15.53M
80.30%-12.77M
106.09%3.25M
47.73%-25.3M
-13.15%-200.4M
32.14%-33.77M
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.4M
Basic earnings per share
77.78%-0.14
55.56%-0.04
77.78%-0.04
105.88%0.01
65.00%-0.07
21.25%-0.63
55.00%-0.09
14.29%-0.18
22.73%-0.17
-17.65%-0.2
Diluted earnings per share
77.78%-0.14
55.56%-0.04
77.78%-0.04
105.88%0.01
65.00%-0.07
21.25%-0.63
55.00%-0.09
14.29%-0.18
22.73%-0.17
-17.65%-0.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 60.24%49.8M-79.31%5.49M710.40%14.18M1,652.64%28.87M11.68%1.26M2,481.48%31.08M3,682.62%26.55M980.25%1.75M419.56%1.65M4,608.33%1.13M
Operating revenue 60.24%49.8M-79.31%5.49M710.40%14.18M1,652.64%28.87M11.68%1.26M2,481.48%31.08M3,682.62%26.55M980.25%1.75M419.56%1.65M4,608.33%1.13M
Cost of revenue -55.52%274K-42.24%201K-85.92%10K-80.12%33K-3.23%30K624.71%616K397.14%348K914.29%71K1,975.00%166K31K
Gross profit 62.58%49.53M-79.81%5.29M744.07%14.17M1,846.86%28.83M12.10%1.23M2,622.52%30.47M4,046.52%26.21M983.23%1.68M379.29%1.48M4,479.17%1.1M
Operating expense -56.75%98.44M-65.95%20.07M-59.68%26.36M-55.84%25.1M-42.04%26.91M31.65%227.58M24.43%58.94M31.31%65.37M27.58%56.84M48.98%46.43M
Selling and administrative expenses -73.92%37.32M-72.85%8.76M-80.80%7.6M-76.14%9.35M-63.79%11.61M25.55%143.1M-1.07%32.26M22.85%39.59M30.61%39.19M67.50%32.06M
-General and administrative expense ------------------------------------67.50%32.06M
Research and development costs -27.65%61.12M-57.60%11.32M-27.24%18.76M-10.75%15.75M6.48%15.3M43.46%84.48M80.77%26.69M46.83%25.78M21.33%17.64M19.51%14.37M
Operating profit 75.19%-48.91M54.85%-14.78M80.87%-12.19M106.75%3.74M43.35%-25.68M-14.77%-197.12M29.95%-32.74M-28.33%-63.69M-25.12%-55.35M-45.57%-45.33M
Net non-operating interest income expense 56.48%-1.43M27.11%-750K47.94%-582K-125.14%-484K112.53%384K38.80%-3.29M65.92%-1.03M-25.06%-1.12M389.91%1.93M-286.87%-3.06M
Non-operating interest income -43.80%6.91M-54.72%1.28M-54.33%1.57M-55.66%1.83M17.78%2.22M58.99%12.29M17.78%2.83M14.61%3.44M219.14%4.14M83.09%1.88M
Non-operating interest expense -46.47%8.34M-47.36%2.03M-52.76%2.16M4.84%2.32M-62.91%1.84M18.91%15.58M-28.83%3.86M17.00%4.56M12.81%2.21M171.72%4.95M
Other net income (expense)
Income before tax 74.88%-50.34M54.01%-15.53M80.30%-12.77M106.09%3.25M47.73%-25.3M-13.15%-200.4M32.14%-33.77M-28.28%-64.81M-18.98%-53.43M-51.55%-48.4M
Income tax
Net income 74.88%-50.34M54.01%-15.53M80.30%-12.77M106.09%3.25M47.73%-25.3M-13.15%-200.4M32.14%-33.77M-28.28%-64.81M-18.98%-53.43M-51.55%-48.4M
Net income continuous Operations 74.88%-50.34M54.01%-15.53M80.30%-12.77M106.09%3.25M47.73%-25.3M-13.15%-200.4M32.14%-33.77M-28.28%-64.81M-18.98%-53.43M-51.55%-48.4M
Minority interest income
Net income attributable to the parent company 74.88%-50.34M54.01%-15.53M80.30%-12.77M106.09%3.25M47.73%-25.3M-13.15%-200.4M32.14%-33.77M-28.28%-64.81M-18.98%-53.43M-51.55%-48.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 74.88%-50.34M54.01%-15.53M80.30%-12.77M106.09%3.25M47.73%-25.3M-13.15%-200.4M32.14%-33.77M-28.28%-64.81M-18.98%-53.43M-51.55%-48.4M
Basic earnings per share 77.78%-0.1455.56%-0.0477.78%-0.04105.88%0.0165.00%-0.0721.25%-0.6355.00%-0.0914.29%-0.1822.73%-0.17-17.65%-0.2
Diluted earnings per share 77.78%-0.1455.56%-0.0477.78%-0.04105.88%0.0165.00%-0.0721.25%-0.6355.00%-0.0914.29%-0.1822.73%-0.17-17.65%-0.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -